FERNANDO
ALFONSO MANTEROLA
Investigador en el periodo 2008-2013
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (34)
2024
-
Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial
JAMA network open, Vol. 7, Núm. 3, pp. e240809
2023
-
Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non-ST-Segment Elevation Acute Myocardial Infarction: A Randomized Clinical Trial
JAMA Internal Medicine, Vol. 183, Núm. 5, pp. 407-415
2022
-
Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement
Canadian Journal of Cardiology, Vol. 38, Núm. 1, pp. 102-112
-
Instantaneous Wave-Free Ratio for the Assessment of Intermediate Left Main Coronary Artery Stenosis: Correlations with Fractional Flow Reserve/Intravascular Ultrasound and Prognostic Implications: The iLITRO-EPIC07 Study
Circulation: Cardiovascular Interventions, Vol. 15, Núm. 11, pp. 861-871
-
Mitral Valve Infective Endocarditis after Trans-Catheter Aortic Valve Implantation
American Journal of Cardiology, Vol. 172, pp. 90-97
-
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 4, pp. 638-646
-
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e417-e427
2021
-
Impact of morbid obesity and obesity phenotype on outcomes after transcatheter aortic valve replacement
Journal of the American Heart Association, Vol. 10, Núm. 12
-
Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement
Journal of the American College of Cardiology, Vol. 77, Núm. 18, pp. 2276-2287
2019
-
Definition of Myocardial Infarction Type 4a: Can We Define Its Diagnosis and Systematize Clinical Practice? Response
Revista Espanola de Cardiologia
-
Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design
Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 154-159
-
Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis
Thrombosis Research, Vol. 177, pp. 180-186
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2016
-
Effects of triple therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention regarding thromboembolic risk stratification
Circulation Journal, Vol. 80, Núm. 2, pp. 354-362
-
Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
PloS one, Vol. 11, Núm. 1, pp. e0147245
-
Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)
American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584
2015
-
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial
Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33
-
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)
EuroIntervention, Vol. 11, Núm. 3, pp. 336-342
2014
-
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)
Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386
-
Comparación de stents de paclitaxel y stents de everolimus en el infarto agudo de miocardio con elevación del segmento ST e influencia de la trombectomía en los resultados. Estudio ESTROFA-IM
Revista Espanola de Cardiologia, Vol. 67, Núm. 12, pp. 999-1006